Acadian Asset Management LLC Affimed N.V. Transaction History

Acadian Asset Management LLC

$34.5 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.32 - $0.62 $5,962 - $11,553	-18,634 Reduced 16.94%	91,385 $57,000
Q3 2023 Nov 13, 2023	SELL	$0.46 - $0.65 $47,586 - $67,241	-103,448 Reduced 48.46%	110,019 $51,000
Q2 2023 Aug 07, 2023	SELL	$0.57 - $1.08 $582,423 - $1.1 Million	-1,021,796 Reduced 82.72%	213,467 $125,000
Q1 2023 May 11, 2023	BUY	$0.66 - $1.29 $531,105 - $1.04 Million	804,705 Added 186.9%	1,235,263 $911,000
Q4 2022 Feb 14, 2023	BUY	$1.1 - $2.45 $420,230 - $935,968	382,028 Added 787.2%	430,558 $529,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.32 $417,762 - $707,638	-213,144 Reduced 81.45%	48,530 $99,000
Q2 2022 Aug 09, 2022	BUY	$2.27 - $4.86 $593,975 - $1.27 Million	261,663 Added 2378754.5%	261,674 $724,000
Q1 2022 May 12, 2022	SELL	$3.69 - $5.65 $1.1 Million - $1.69 Million	-298,971 Reduced 100.0%	11 $0
Q4 2021 Feb 10, 2022	SELL	$5.37 - $7.07 $1.88 Million - $2.48 Million	-350,902 Reduced 53.99%	298,982 $1.65 Million
Q3 2021 Nov 12, 2021	BUY	$5.54 - $7.51 $383,251 - $519,534	69,179 Added 11.91%	649,884 $4.01 Million
Q2 2021 Aug 11, 2021	SELL	$7.78 - $11.4 $5.25 Million - $7.69 Million	-674,931 Reduced 53.75%	580,705 $4.94 Million
Q1 2021 May 11, 2021	SELL	$5.12 - $8.48 $3.06 Million - $5.06 Million	-596,966 Reduced 32.22%	1,255,636 $9.93 Million
Q4 2020 Feb 11, 2021	SELL	$3.16 - $7.03 $150,975 - $335,872	-47,777 Reduced 2.51%	1,852,602 $10.8 Million
Q3 2020 Nov 09, 2020	SELL	$3.26 - $4.73 $2.3 Million - $3.34 Million	-706,733 Reduced 27.11%	1,900,379 $6.44 Million
Q2 2020 Aug 12, 2020	BUY	$1.58 - $4.63 $4.12 Million - $12.1 Million	2,607,112 New	2,607,112 $12 Million
Q1 2020 May 11, 2020	SELL	$1.44 - $3.02 $4.42 Million - $9.27 Million	-3,070,402 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$2.25 - $3.07 $6.91 Million - $9.43 Million	3,070,402 New	3,070,402 $8.41 Million
Q3 2019 Nov 07, 2019	SELL	$2.67 - $3.65 $5.81 Million - $7.94 Million	-2,176,604 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$2.6 - $4.21 $5.5 Million - $8.91 Million	2,116,546 Added 3524.17%	2,176,604 $6.25 Million
Q1 2019 May 09, 2019	BUY	$3.05 - $4.34 $183,176 - $260,651	60,058 New	60,058 $253,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $155M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account